| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_240e1cd00a69820e67a50d867333fd02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41801b66f513d26180580b866dd79681 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
| filingDate |
2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbe8e10349e4fca400650a260aa920b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c07f1637b9ec926b0ec2c07e3bb3fd2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_942048b5209bcf3eb95736aa23dc67c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a82584be8e60c75dc582ca62655831cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66c624043e2f8ab99b9b534428290640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e67ffa9c85ce682bbc0adfe7ee1603d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa55ead98f9384f4f9de9aa82cb5b212 |
| publicationDate |
2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-102020009949-A2 |
| titleOfInvention |
Process of synthesis of glutaminase-inhibiting compounds and glutaminase-inhibiting compounds thus obtained |
| abstract |
process of synthesis of glutaminase-inhibiting compounds and glutaminase-inhibiting compounds thus obtained. the present invention relates to a process for the synthesis of new heterocyclic compounds containing the 3-thio-1,2,4triazole system as glutaminase inhibitors and the glutaminase inhibitor compounds thus obtained. the compounds obtained in the present invention can be used as glutaminase inhibitors and have potential application in the treatment of cancer, more specifically breast cancer. |
| priorityDate |
2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |